These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 33758147

  • 21. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
    Tanaka R, Maruyama H, Tomidokoro Y, Yanagiha K, Hirabayashi T, Ishii A, Okune M, Inoue S, Sekine I, Tamaoka A, Fujimoto M.
    Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Neurotoxicities associated with immune checkpoint inhibitor therapy.
    Duong SL, Barbiero FJ, Nowak RJ, Baehring JM.
    J Neurooncol; 2021 Apr; 152(2):265-277. PubMed ID: 33454891
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
    Verboon C, van den Berg B, Cornblath DR, Venema E, Gorson KC, Lunn MP, Lingsma H, Van den Bergh P, Harbo T, Bateman K, Pereon Y, Sindrup SH, Kusunoki S, Miller J, Islam Z, Hartung HP, Chavada G, Jacobs BC, Hughes RAC, van Doorn PA, IGOS Consortium.
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):113-121. PubMed ID: 31586949
    [Abstract] [Full Text] [Related]

  • 32. IVIg-induced plasmablasts in patients with Guillain-Barré syndrome.
    Brem MD, Jacobs BC, van Rijs W, Fokkink WJR, Tio-Gillen AP, Walgaard C, van Doorn PA, IJspeert H, van der Burg M, Huizinga R.
    Ann Clin Transl Neurol; 2019 Jan; 6(1):129-143. PubMed ID: 30656191
    [Abstract] [Full Text] [Related]

  • 33. Recognizing encephalopathy in immune checkpoint inhibitor therapy: A single-center experience.
    Wei D, Zhou DJ, Datta P, Taraschenko O.
    Cancer Med; 2021 May; 10(9):2978-2986. PubMed ID: 33660430
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic Review.
    Velasco R, Villagrán M, Jové M, Simó M, Vilariño N, Alemany M, Palmero R, Martínez-Villacampa MM, Nadal E, Bruna J.
    JAMA Neurol; 2021 Jul 01; 78(7):864-873. PubMed ID: 33720308
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study.
    Verboon C, Harbo T, Cornblath DR, Hughes RAC, van Doorn PA, Lunn MP, Gorson KC, Barroso F, Kuwabara S, Galassi G, Lehmann HC, Kusunoki S, Reisin RC, Binda D, Cavaletti G, Jacobs BC, IGOS consortium, GOS consortium.
    J Neurol Neurosurg Psychiatry; 2021 Oct 01; 92(10):1080-1088. PubMed ID: 34103340
    [Abstract] [Full Text] [Related]

  • 39. Delayed immune-related neutropenia with hepatitis by pembrolizumab.
    Nakako S, Nakashima Y, Okamura H, Tani Y, Ueda T, Makuuchi Y, Kuno M, Takakuwa T, Nishimoto M, Koh H, Nakamae H, Hino M.
    Immunotherapy; 2022 Feb 01; 14(2):101-105. PubMed ID: 34758635
    [Abstract] [Full Text] [Related]

  • 40. Immune checkpoint inhibitor-induced pure red cell aplasia: Case series and large-scale pharmacovigilance analysis.
    Guo Q, Gao J, Guo H, Xie J, Cheng J.
    Int Immunopharmacol; 2023 Jan 01; 114():109490. PubMed ID: 36459923
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.